NCT07463859

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of periodontal treatment associated with the use of a tongue scraper, compared with the same treatment combined with antimicrobial photodynamic therapy (aPDT), in reducing halitosis in individuals with periodontal disease and type 2 diabetes mellitus. The main question it aims to answer is: aPDT treatment is more effective in treating halitosis? aPDT treatment is more effective in periodontitis? Researchers will compare aPDT treatment to conventional treatment (scaling and root planning and tongue scraper) to see if aPDT has additional effects in reducing halitosis and improving periodontal health.

  • Participants will be asked to visit the clinic once a week for exam and treatment during 1 month.
  • After active treatment they will be asked to come to maintenance and control visits once a month until 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes

Timeline
9mo left

Started Apr 2026

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Apr 2026Feb 2027

First Submitted

Initial submission to the registry

March 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

April 2, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2027

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

March 5, 2026

Last Update Submit

March 11, 2026

Conditions

Keywords

HalitosisperiodontitislasersPhotodynamic Therapy

Outcome Measures

Primary Outcomes (1)

  • Halitosis

    Measurement of oral volatile compounds by gas chromatography

    From enrollment to the end of treatment at 6 months

Secondary Outcomes (2)

  • Probing depth

    From enrollment to the end of treatment at 6 months

  • Clinical Attachment level

    From enrollment to the end of treatment at 6 months

Study Arms (2)

aPDT - antimicrobial photodynamic therapy

EXPERIMENTAL

Treatment of scaling and root planning plus antimicrobial photodynamic therapy in periodontal pockets. Antimicrobial photodynamic therapy on tongue.

Procedure: Photodynamic Therapy with Conventional Methylene Blue

Control

ACTIVE COMPARATOR

Treatment of periodontal pockets with scaling and root planing and tongue with tongue scraper

Procedure: Scaling and root planing

Interventions

Mechanical removal of biofilm in periodontal pockets and tongue

Control

Antimicrobial photodynamic therapy in periodontal pockets and tongue

aPDT - antimicrobial photodynamic therapy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with type 2 diabetes mellitus according to the 2019 WHO criteria
  • Stage 3 or 4 periodontitis
  • No periodontal treatment in the previous 12 months
  • a minimum of 20 remaining teeth.

You may not qualify if:

  • Smokers
  • Alcohol-dependent individuals
  • Pregnant or lactating women
  • Patients with renal disorders
  • Patients using medications that affect the periodontium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bauru School of Dentistry

Bauru, São Paulo, 17012901, Brazil

RECRUITING

Related Publications (2)

  • Bruno LH,Mandetta ARH,Sobral APT,Leal Gonçalves ML,Santos EM,Fossati AL,Gallo JMAS,Motta PB,Deana AM,Horliana ACRT,Motta LJ,Ferrari RAM,Santos Fernandes KP,Kalil Bussadori S

    BACKGROUND
  • da Mota ACC, Goncalves MLL, Horliana ACRT, Deana AM, de Souza Cavalcante LA, Gomes AO, Mayer MPA, Suguimoto ESA, Fernandes KPS, Mesquita-Ferrari RA, Prates RA, Motta LJ, Bussadori SK. Effect of antimicrobial photodynamic therapy with red led and methylene blue on the reduction of halitosis: controlled microbiological clinical trial. Lasers Med Sci. 2022 Mar;37(2):877-886. doi: 10.1007/s10103-021-03325-x. Epub 2021 May 13.

    PMID: 33987732BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HalitosisPeriodontitis

Interventions

Tooth ExfoliationRoot PlaningPhotochemotherapy

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive DentistryCombined Modality TherapyTherapeuticsDrug TherapyPhototherapy

Central Study Contacts

Carla A. Damante, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Simulation of laser treatment
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor - Principal investigator

Study Record Dates

First Submitted

March 5, 2026

First Posted

March 11, 2026

Study Start

April 2, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

February 28, 2027

Last Updated

March 16, 2026

Record last verified: 2026-03

Locations